A protocol for a randomized controlled trial comparing Sleepwell\EMPOWER and treatment as usual for benzodiazepine receptor agonist discontinuation in older adults - The your answers when needing sleep in New Brunswick (YAWNS NB) study | UNB

Global Site Navigation (use tab and down arrow)

NB-IRDT

A protocol for a randomized controlled trial comparing Sleepwell\EMPOWER and treatment as usual for benzodiazepine receptor agonist discontinuation in older adults - The your answers when needing sleep in New Brunswick (YAWNS NB) study

Author: Andrea L. Murphy, Justin P. Turner, Malgorzata Rajdae, Sandra Magalhaes, Kathleen G. Allen, David M. Gardner
Year: 2022
Category: Health Publications

Read the journal article in Exploratory Research in Clinical and Social Pharmacy

Chronic benzodiazepine receptor agonist (BZRA) use among older adults is a public health concern given cognitive and physical risks. One in four older adults in New Brunswick (NB), Canada, is a long-term user of BZRAs. Previous studies using direct-to-consumer approaches with patients as the primary intervention target have shown promise in reducing BZRAs. The Your Answers When Needing Sleep in New Brunswick (YAWNS NB) study aims to reduce the long-term use of BZRAs in older adults and increase the use of cognitive behavioural therapy for insomnia (CBTi), which is the recommended first line treatment.